197 related articles for article (PubMed ID: 31840543)
1. Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review.
Zeng B; Yuan L; Chu J; Yang Y; Lin S
J Int Med Res; 2020 Mar; 48(3):300060519891018. PubMed ID: 31840543
[TBL] [Abstract][Full Text] [Related]
2. Case report: Severe cholestatic jaundice associated with hyperthyroidism treated with methimazole.
Liu X; Xu B; Zeng Y; Chen P; Wang Y
Medicine (Baltimore); 2023 Nov; 102(45):e35972. PubMed ID: 37960740
[TBL] [Abstract][Full Text] [Related]
3. Cholestasis secondary to hyperthyroidism made worse by methimazole.
Majeed M; Babu A
Am J Med Sci; 2006 Jul; 332(1):51-3. PubMed ID: 16845245
[TBL] [Abstract][Full Text] [Related]
4. [Hyperthyroidism and cholestasis: a case report].
Gurioli L; Babini G; Rizzi R; Bertello P
Ann Ital Med Int; 1998; 13(4):244-7. PubMed ID: 10349208
[TBL] [Abstract][Full Text] [Related]
5. Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine.
Hasan MK; Tierney WM; Baker MZ
Am J Med Sci; 2004 Dec; 328(6):348-50. PubMed ID: 15599331
[TBL] [Abstract][Full Text] [Related]
6. Cholestasis induced hyperthyroidism after liver transplantation.
Lersch C; Seige M; Natrath W; Heidecke W; Wittekind C; Classen M; Schepp W
Digestion; 1995; 56(5):429-32. PubMed ID: 8549888
[TBL] [Abstract][Full Text] [Related]
7. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
8. [Acquired sideroblastic anemia and cholestasis in a hyperthyroid patient treated with methimazole and atenolol].
Mamianetti A; Muñoz A; Ronchetti RD; Maccione E; Poggi U; Mugnolo R; Gallo O
Medicina (B Aires); 1995; 55(6):693-6. PubMed ID: 8731582
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury].
Sheng QJ; Ding Y; Zhang C; Han C; Li YW; Fan YX; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):967-971. PubMed ID: 34814390
[No Abstract] [Full Text] [Related]
10. SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
Niculescu DA; Dusceac R; Galoiu SA; Capatina CA; Poiana C
Endocr Pract; 2016 Aug; 22(8):974-9. PubMed ID: 27042749
[TBL] [Abstract][Full Text] [Related]
11. Recurrent apathetic hyperthyroidism.
Peake RL
Arch Intern Med; 1981 Feb; 141(2):258-60. PubMed ID: 6161590
[TBL] [Abstract][Full Text] [Related]
12. Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature.
Yang J; Zhang J; Xu Q; Sheng GP; Weng WW; Dong MJ
Int J Endocrinol; 2015; 2015():934726. PubMed ID: 26060496
[TBL] [Abstract][Full Text] [Related]
13. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole.
Arab DM; Malatjalian DA; Rittmaster RS
J Clin Endocrinol Metab; 1995 Apr; 80(4):1083-5. PubMed ID: 7714072
[No Abstract] [Full Text] [Related]
14. Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.
Mori Y; Hiromura M; Terasaki M; Kushima H; Ohara M; Fukui T; Takahashi Y; Yamagishi SI
J Int Med Res; 2021 Mar; 49(3):300060521996192. PubMed ID: 33682498
[TBL] [Abstract][Full Text] [Related]
15. Cholestasis secondary to hyperthyroidism in Graves' disease. Report of one case.
Barra MI; Olmos R; Barrera F; Mosso L; Domínguez JM
Rev Med Chil; 2020 May; 148(5):697-701. PubMed ID: 33399764
[TBL] [Abstract][Full Text] [Related]
16. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
Abuid J; Larsen PR
J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
[TBL] [Abstract][Full Text] [Related]
17. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
18. Graves' disease presenting with severe cholestasis.
Regelmann MO; Miloh T; Arnon R; Morotti R; Kerkar N; Rapaport R
Thyroid; 2012 Apr; 22(4):437-9. PubMed ID: 22458973
[TBL] [Abstract][Full Text] [Related]
19. Unusual thyroid scintigrams in Plummer's disease during methimazole therapy. Conversion of hot to hypofunctional nodules.
Tamai H; Nagai K; Ishimoto J; Matsubayashi S; Matsuzuka F; Miyauchi A; Kuma K; Nagataki S
Clin Nucl Med; 1990 Jul; 15(7):465-7. PubMed ID: 2102667
[TBL] [Abstract][Full Text] [Related]
20. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
Azizi F; Khoshniat M; Bahrainian M; Hedayati M
J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
